Latest Licensing News

Bass Oil Limited is set to deepen its exploration of the Triassic gas play in the northern Cooper Basin following a successful flow test at the Kiwi gas field, signaling significant potential for future discoveries and development.

Polymetals has raised $35 million through a share placement to fund the restart of its Endeavor silver and zinc mine and accelerate exploration efforts, positioning the company for production in Q2 2025.

Advance Metals has secured $1.52 million to fund diamond drilling at its Myrtleford Project in Victoria and confirmatory drilling at its Yoquivo Silver Project in Mexico, with drilling commencing immediately.

Wellnex Life Limited has initiated a $22.1 million entitlement offer priced at $0.65 per share, coinciding with its proposed dual listing on the London Stock Exchange's AIM market, driven by strong UK institutional interest.

BTC Health has transformed its decade-long license agreement with Arna Pharma into an indefinite partnership, gaining royalties from Singapore and Malaysia sales and first rights to new pharmaceutical products in Australia and New Zealand.

Terramin Australia has lodged an appeal after the Supreme Court dismissed its mining lease application for the Bird in Hand Gold Project, underscoring the project's significant economic and environmental potential for South Australia.

DMC Mining Limited has extended the closing date for its public share offer to May 8, 2025, due to delays in obtaining exploration licenses for its Firawa and Labe Projects in Guinea. The company plans to lodge a second supplementary prospectus to adjust regulatory conditions accordingly.

Neuren Pharmaceuticals has received a significant cash inflow of approximately US$50 million following the sale of a Priority Review Voucher linked to its Rett syndrome treatment. This milestone underscores the growing value of Neuren’s neurological drug portfolio and its partnership with Acadia Pharmaceuticals.

Acrux Limited announces the retirement of CEO Michael Kotsanis after more than 10 years at the helm, with a search underway for his successor to lead the next phase of growth.

Adelong Gold Limited has raised $1.173 million through a placement to fund exploration and development at its NSW gold project and lithium ventures in Brazil. The capital raise, including free attaching options, signals investor confidence as the company advances towards production.

Invex Therapeutics reports a significant reduction in net loss for H1 FY2025 alongside promising pre-clinical data for Exenatide in Alzheimer’s Disease models.

Evion Group has raised $2 million through a Rights Issue and Shortfall Placement to accelerate expansion of its Panthera Graphite JV, aiming to double production capacity amid strong global demand.